Premium
Inhibition of Mitochondrial Biosynthesis Using a “Right‐Side‐Out” Membrane‐Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple‐Negative Breast Cancer (Adv. Healthcare Mater. 18/2022)
Author(s) -
Peng Jianqing,
Hu Xiaoxia,
Fan Shuangqin,
Zhou Jia,
Ren Shuang,
Sun Runbin,
Chen Yi,
Shen Xiangchun,
Chen Yan
Publication year - 2022
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.202270109
Subject(s) - triple negative breast cancer , mitochondrion , chemistry , cancer , cancer research , medicine , nanotechnology , breast cancer , materials science , biochemistry
Biomimetics In article number 2200742 by Yi Chen, Xiangchun Shen, Yan Chen, and co‐workers, a “right‐side‐out” membrane‐cloaking micelle is engineered for mitochondria‐targeted delivery of shikonin. Inspired by the stories from “Journey to the West”, the monkey king blowing the camouflaged blue elixir to put out a fire is used to represent targeted delivery of shikonin to mitochondria that improves its therapeutic effects on triple‐negative breast cancer.